ELI LILLY & Co

Insider Reports History

Location
Indianapolis, IN
Signature
/s/ Christopher Anderson, Vice President, Leader of Corporate Securities and Assistant Corporate Secretary
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by ELI LILLY & Co:

Company Role Class Num Shares Value Price $ Report Date Ownership
Aktis Oncology, Inc. 10%+ Owner Common Stock 6,344,114 $135,446,834 $21.35 12 Jan 2026 Direct
Sigilon Therapeutics, Inc. 10%+ Owner Common Stock 100 11 Aug 2023 Direct

Insider Reports Filed by ELI LILLY & Co

Symbol Company Period Transactions Value $ Form Type Role Filing Time
AKTS Aktis Oncology, Inc. 12 Jan 2026 0 $0 3 10%+ Owner 15 Jan 2026, 06:01
/report/000089924323018115-eli-lilly-co-2023-08-11 Sigilon Therapeutics, Inc. 11 Aug 2023 1 +$25,639,916 4 10%+ Owner 14 Aug 2023, 16:30
/report/000089924323017270-eli-lilly-co-2023-06-28 Sigilon Therapeutics, Inc. 28 Jun 2023 0 $0 3 10%+ Owner 07 Jul 2023, 16:30